Status:
RECRUITING
Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia
Lead Sponsor:
Hospital de la Florida Dra. Eloiza Diaz
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
A randomised, controlled, double-blind clinical trial will be carried out to evaluate the effectiveness of a VR assisted treatment for negative symptoms in people with schizophrenia. Patients with a s...
Eligibility Criteria
Inclusion
- Diagnosis of schizophrenia made by the treating psychiatrist and corroborated by a team's psychiatrist under CIE-10 criteria.
- Age between 18 to 65 years-old.
- Outpatient setting,
- Clinical stability defined as no psychiatric hospitalizations in the last 6 months and not currently on queue for psychiatric hospitalization.
- No concomitant active substance abuse disorder, excluding nicotine.
- Subjects are capable of providing informed consent.
Exclusion
- Previous diagnosis of learning disability according either to ICD- 10 or clinical history
- Verbal expression difficulties, determined by language or medical causes.
- Deafness and/or blindness.
- Other physical handicaps to use VR devices.
- Predominant positive symptoms, defined as PANNS-C \> 0.
- Catatonic symptoms.
- Previous epilepsy diagnosis.
- Neurodegenerative disease.
Key Trial Info
Start Date :
May 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06588270
Start Date
May 2 2022
End Date
September 1 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínico La Florida
Santiago, Santiago Metropolitan, Chile